Results 311 to 320 of about 258,738 (344)
Some of the next articles are maybe not open access.
Thyroid lymphoma. The case for combined modality therapy
Cancer, 1994Radiation therapy with or without surgery is generally considered standard treatment for lymphoma of the thyroid. Because of the small number of cases, the role of chemotherapy or combined modality treatment is difficult to determine.The published literature was analyzed, supplemented by a series from Yale, for the incidence of local and distant ...
Raul Doria +2 more
openaire +3 more sources
Postoperative Adjuvant Combined Modality Therapy
2001Significant advances have been made in the adjuvant management of resectable rectal cancer during the 1990s. In patients with clinically resectable disease, pelvic radiation therapy decreases local recurrence. The addition of systemic chemotherapy further decreases local recurrence and improves survival.
C. H. Kohne, Bruce D. Minsky, C. Greco
openaire +2 more sources
The Necessity for Combined Modalities in Cancer Therapy
Hospital Practice, 1973Evidence is abundant that cure of cancer cannot be consistently achieved by a single modality and that the goal of destruction of every cancer cell can be attained only by immunotherapy. But this technique is effective against only a relatively small tumor-cell burden.
openaire +2 more sources
Combined Modality Therapy in Cancer Management
2010The last 30 years have ushered in a convincing argument that combining chemotherapeutic drugs, with actions against specific aspects of the cancer cell cycle or DNA, with ionizing radiation results in clinically meaningful improvements in locoregional control and survival in many epithelial cancers and gliomas.
Kyle E. Rusthoven, David Raben
openaire +2 more sources
Cancer of the Gastroesophageal Junction: Combined Modality Therapy
Surgical Oncology Clinics of North America, 2006Esophageal cancer, an uncommon, but highly virulent malignancy in the United States, will be responsible for nearly 14,000 deaths in the year 2005. The prognosis for patients who have adenocarcinoma of the distal esophagus and gastroesophageal junction and who are treated with the standard approaches of surgery or combined chemoradiation therapy is ...
openaire +3 more sources
Adjuvant combined modality therapy for malignant meningiomas
Journal of Neurosurgery, 1996✓ Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment of these aggressive primary brain tumors. Fourteen patients (eight men, six women), ranging in age from 28 to 61 years (median 51 years), were prospectively treated for primary malignant meningiomas according to an institutional ...
openaire +3 more sources
Future of combined modality therapy
International Journal of Radiation Oncology*Biology*Physics, 1981openaire +3 more sources